Pharma & Biotech

Hikma Pharmaceuticals has been demoted from the UK's premier stock market index. Effective from the start of trading on Monday,...

Nvidia is broadening its horizons. The chipmaker's latest collaborations with major utility and pharmaceutical firms signal a deliberate push to...

The investment narrative surrounding BioNTech is currently being shaped by a confluence of challenges. Despite the company's strategic moves to...

ImmunityBio is making a prominent appearance at the 38th Annual ROTH Conference this week, a move underscored by a remarkable...

The competitive landscape for Germany's online pharmacy market is intensifying. Rossmann has announced its intention to launch an online pharmacy...

Novo Nordisk convenes its annual general meeting this Thursday against a backdrop of significant challenges. Two pivotal events define the...

Redcare Pharmacy is poised for a significant leadership transition at the highest level of its supervisory board. The upcoming Annual...

Valneva's recently published 2025 annual results reveal a company at a strategic crossroads. While its core business demonstrates resilience, the...

Investors in Bluechiip Limited have now received definitive confirmation of a total loss. The company's journey, which began with the...

The year 2026 is shaping up to be a decisive period for BioNTech as it seeks to solidify its transition...